Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0759
D

Medication Error Rate Exceeds 5% Due to Insulin and Omeprazole Administration Errors

Adel, Iowa Survey Completed on 04-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to maintain a medication error rate below 5%, as evidenced by 2 errors out of 30 observed medication administration opportunities, resulting in a 6.67% error rate. One incident involved a resident with diabetes who was prescribed Novolog insulin via a sliding scale. The nurse administered the insulin dose based on an outdated sliding scale taped inside the resident's supply bin, rather than the current order in the electronic medication administration record (EMAR). Additionally, the nurse did not prime the insulin pen prior to administration, contrary to manufacturer instructions. Interviews revealed inconsistent practices among staff regarding verification of insulin orders and updating of sliding scale references in the medication bins, with some staff relying on printed orders and others on the EMAR. The Director of Nursing acknowledged that the process for updating sliding scale orders in the bins was not consistently followed, and there was no facility policy for insulin flexpen administration. Another error involved a resident with GERD and dysphagia who was prescribed omeprazole delayed release (DR) capsules to be administered in the morning. The certified medication aide crushed the omeprazole DR capsule along with other medications and administered the mixture with applesauce while the resident was eating breakfast. According to the pharmacist, omeprazole DR should not be crushed, as this alters its delayed-release properties, and it should be given 30 to 60 minutes before a meal. Facility policy also states that long-acting or enteric-coated medications should not be crushed and that alternatives should be sought if necessary, with pharmacist consultation required. Both incidents demonstrate failures to follow physician orders, manufacturer instructions, and facility policy regarding medication administration. The errors were directly observed during surveyor review, and staff interviews confirmed lapses in verifying current orders and proper medication administration techniques. The facility's lack of a specific policy for insulin flexpen use and inconsistent updating of medication instructions contributed to the deficiencies.

An unhandled error has occurred. Reload 🗙